Betta Pharmaceuticals Co., Ltd. (300558.SZ) SHZ
Currency In CNY
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In CNY
Address
No. 355, Xingzhong Road
Hangzhou, ZH 311100
China
Phone
86 571 8613 0357
Website
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
1785
First IPO Date
November 09, 2016
| Name | Title | Pay | Year Born |
| Lieming Ding | Founder, Chairman of the Board, Chief Executive Officer & GM | 0 | 1963 |
| Jia Tong | CEO & Director | 0 | 1977 |
| Lingxi Wu | Board Secretary & Head of Chairman Office | 0 | 1983 |
| Jianxun Fan | Vice President, Chief Financial Officer & Director | 0 | 1971 |
| Shi Zhe Ding | Director & Assistant to the Chairman | 0 | 1991 |
| Hena Shi | VP, COO & General Manager of Oncology Business Department | 0 | N/A |
| Jiang Wan | Senior VP, President of Global Sales & Director | 0 | 1968 |
| Mao Li | President of R&D, Chief Medical Officer & Director | 0 | 1957 |
| Weisheng Huang | Chief Chemist | 0 | N/A |
Betta Pharmaceuticals Co., Ltd. is a Chinese pharmaceutical company dedicated to the discovery, development, manufacturing, and commercialization of oncology treatments. Among its key offerings are Icotinib hydrochloride, an orally taken epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, and Ensartinib hydrochloride, an anaplastic lymphoma kinase (ALK) inhibitor, both utilized in the management of non-small-cell lung cancer. Founded in 2003, the firm is headquartered in Hangzhou, China.